Here, we performed a streamlined approach with in silico and in vitro analyses starting from 38 epigenetic targets to select the most relevant for lung cancer cell treatment and showed that the inhibition of PADI4 and KDM6B proteins controls the metastatic process, inhibiting cancer cell migration and invasion by altering their transcriptomes. The gene discussed is PADI4; the disease is cancer.